- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01776593
The Best Parameter of Bladder Diary Correlates With the Volume at Strong Desire to Void of Filling Cystometry
January 23, 2013 updated by: National Taiwan University Hospital
To identify the bladder diary parameters that are best correlated to VSD.
Study Overview
Status
Completed
Conditions
Detailed Description
To identify the bladder diary parameters that are best correlated to VSD.
Study Type
Observational
Enrollment (Actual)
900
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 100
- Department of Obstetrics & Gynecology, National Taiwan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Female patients with lower urinary tract symptoms
Description
Inclusion Criteria:
- Female patients with lower urinary tract symptoms who had underwent urodynamic studies
Exclusion Criteria:
- Patients without data of bladder diary
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Lower urinary tract symptoms
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To identify the bladder diary parameter that is best correlated to the volume at strong desire to void of filling cystometry.
Time Frame: 1 week
|
To identify which bladder diary parameter that is best correlated to the volume at strong desire to void of filling cystometry.
Thus, that bladder diary parameter may be used as a surrogate for the volume of strong desire to void of filling cystometry and without the need of urodynamic studies.
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2012
Primary Completion (Actual)
July 1, 2012
Study Completion (Actual)
July 1, 2012
Study Registration Dates
First Submitted
January 18, 2013
First Submitted That Met QC Criteria
January 23, 2013
First Posted (Estimate)
January 28, 2013
Study Record Updates
Last Update Posted (Estimate)
January 28, 2013
Last Update Submitted That Met QC Criteria
January 23, 2013
Last Verified
January 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- 201203078RIC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bladder Diary
-
University of BarcelonaRecruitingDepression | Quality of Life | Stress | Anxiety | Intensive Care Unit | Family | Patient | PICS | Diary (Blank Journal)Spain
-
University of California, San FranciscoRecruitingBladder Dysfunction | Postpartum Bladder Dysfunction | Post-prostatectomy Bladder DysfunctionUnited States
-
Sheba Medical CenterUnknown
-
Ain Shams UniversityCompletedThe Outcome of Pre-transplant Bladder Cycling in Patients With Defunctionalized Bladder (PBC and DF)Bladder Cycling, Defunctionalized BladderEgypt
-
Novartis PharmaceuticalsTerminatedNeurogenic Urinary Bladder | Neurogenic Bladder Disorder | Neurogenic Dysfunction of the Urinary Bladder | Neurogenic Bladder, Uninhibited | Neurogenic Bladder, SpasticNetherlands, Germany, Switzerland
-
Peking University First HospitalRecruitingUrinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder Tumors | Neoplasms, BladderChina
-
Mansoura UniversityCompletedBladder Cancer | Bladder Disease | Bladder Neoplasm | Micro-RNAEgypt
-
EchoNous Inc.Rainier Clinical Research CenterCompletedBladder Disease | Bladder Function | Bladder Dysfunction | Bladder Retention VolumeUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedMuscle-Invasive Bladder Carcinoma | Bladder Cancer Stage II | Bladder Cancer Stage III | Bladder Cancer Stage IVUnited States